Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway
Journal of Integrative Neuroscience · 12.08.2024 · 23 (8)
DOI: 10.31083/j.jin2308142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 12.08.2024. Verfasst von Yao Xing und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Jinzhou Medical University, 121001 Jinzhou, Liaoning, China. Hauptthemen laut MEDLINE: Brain Ischemia, Fingolimod Hydrochloride, Signal Transduction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Clinically, ischemic reperfusion injury is the main cause of stroke injury. This study aimed to assess the effectiveness of fingolimod in suppressing inflammation caused by ischemic brain injury and explore its pharmacological mechanisms.
Methods
In total, 75 male Sprague-Dawley rats were randomly and equally assigned to five distinct groups: sham, middle cerebral artery occlusion/reperfusion (MCAO/R) surgery, fingolimod low-dose (F-L), fingolimod medium-dose (F-M), and fingolimod high-dose (F-H). Neurobehavioral tests, 2,3,5-triphenyltetrazolium chloride staining, and the brain tissue drying-wet method were conducted to evaluate neurological impairment, cerebral infarction size, and brain water content. Enzyme-linked immunosorbent assay was employed to quantify pro-inflammatory cytokines interleukin (IL)-1β, IL-6, and tumor necrosis factor-alpha (TNF-α) protein levels. Western blotting and immunohistochemical staining were performed to assess high mobility group box 1 (HMGB1), toll-like receptor 4 (TLR4), and nuclear factor kappa-B p65 (NF-κBp65) levels.
Results
Rats in the F-L, F-M, and F-H groups exhibited lower Longa scores, reduced infarction volumes, and decreased brain edema than those in the MCAO/R group. Additionally, the F-L, F-M, and F-H groups exhibited lower serum levels of IL-1β, IL-6, and TNF-α than those of the MCAO/R group. Additionally, F-L, F-M, and F-H treatments resulted in decreased HMGB1, TLR4, and NF-κBp65 protein expression levels in the hippocampus of MCAO/R rats.
Conclusions
Fingolimod was found to reduce ischemic brain injury in a dose-dependent manner. Moreover, it was also found to alleviate inflammation following ischemic brain injury via the HMGB1/TLR4/NF‑κB signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Jinzhou Medical University, 121001 Jinzhou, Liaoning, China.
- Institute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.
- Department of Neurology, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xing, Y., Zhong, L., Guo, J., Bao, C., Luo, Y., & Min, L. (2024). Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway. Journal of Integrative Neuroscience, 23(8). https://doi.org/10.31083/j.jin2308142
Vancouver
Xing Y, Zhong L, Guo J, Bao C, Luo Y, Min L. Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway. Journal of Integrative Neuroscience. 2024;23(8). doi:10.31083/j.jin2308142
BibTeX
@article{Xing2024,
author = {Xing, Yao and Zhong, Liyuan and Guo, Jun and Bao, Cuifen and Luo, Yumin and Min, Lianqiu},
title = {Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway},
journal = {Journal of Integrative Neuroscience},
year = {2024},
volume = {23},
number = {8},
doi = {10.31083/j.jin2308142}
}
EUVIMED